Global Pharmaceutical Single Dose Packaging 麻豆原创 Research Report 2024

Publication ID:

PB507242445

Publication Date:

July 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Packaging [2]

Industry & Manufacturing [3]

Description:

The global Pharmaceutical Single Dose Packaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Single Dose Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Single Dose Packaging.
Report Scope
The Pharmaceutical Single Dose Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Single Dose Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Single Dose Packaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Pfizer Inc.
Johnson & Johnson
Merck & Co. Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UDG Healthcare plc
Comar LLC
Berry Global
Gerresheimer AG
Amcor plc
Segment by Type
Prefilled Syringes Cartridges
Prefilled Syringes Cartridges
Vials Pharmaceutical Unit Dose Packaging
Ampoules Pharmaceutical Unit Dose Packaging
Blisters Pharmaceutical Unit Dose Packaging
Others
Segment by Application
Orals
Respiratory Therapy
Wound Care
Biologics
Injectable
Ophthalmic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Single Dose Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Single Dose Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pharmaceutical Single Dose Packaging 麻豆原创 Overview
1.1 Product Overview and Scope of Pharmaceutical Single Dose Packaging
1.2 Pharmaceutical Single Dose Packaging Segment by Type
1.2.1 Global Pharmaceutical Single Dose Packaging 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Prefilled Syringes Cartridges
1.2.3 Prefilled Syringes Cartridges
1.2.4 Vials Pharmaceutical Unit Dose Packaging
1.2.5 Ampoules Pharmaceutical Unit Dose Packaging
1.2.6 Blisters Pharmaceutical Unit Dose Packaging
1.2.7 Others
1.3 Pharmaceutical Single Dose Packaging Segment by Application
1.3.1 Global Pharmaceutical Single Dose Packaging 麻豆原创 Value by Application: (2024-2030)
1.3.2 Orals
1.3.3 Respiratory Therapy
1.3.4 Wound Care
1.3.5 Biologics
1.3.6 Injectable
1.3.7 Ophthalmic
1.3.8 Others
1.4 Global Pharmaceutical Single Dose Packaging 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Single Dose Packaging Revenue 2019-2030
1.4.2 Global Pharmaceutical Single Dose Packaging Sales 2019-2030
1.4.3 Global Pharmaceutical Single Dose Packaging 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Single Dose Packaging 麻豆原创 Competition by Manufacturers
2.1 Global Pharmaceutical Single Dose Packaging Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Single Dose Packaging Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Single Dose Packaging Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Single Dose Packaging Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Single Dose Packaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Single Dose Packaging, Product Type & Application
2.7 Pharmaceutical Single Dose Packaging 麻豆原创 Competitive Situation and Trends
2.7.1 Pharmaceutical Single Dose Packaging 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Single Dose Packaging Players 麻豆原创 Share by Revenue
2.7.3 Global Pharmaceutical Single Dose Packaging 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Single Dose Packaging Retrospective 麻豆原创 Scenario by Region
3.1 Global Pharmaceutical Single Dose Packaging 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Single Dose Packaging Global Pharmaceutical Single Dose Packaging Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Single Dose Packaging Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Single Dose Packaging Sales by Region: 2025-2030
3.3 Global Pharmaceutical Single Dose Packaging Global Pharmaceutical Single Dose Packaging Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Single Dose Packaging Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Single Dose Packaging Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Single Dose Packaging 麻豆原创 Facts & Figures by Country
3.4.1 North America Pharmaceutical Single Dose Packaging 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Single Dose Packaging Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Single Dose Packaging Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Single Dose Packaging 麻豆原创 Facts & Figures by Country
3.5.1 Europe Pharmaceutical Single Dose Packaging 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Single Dose Packaging Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Single Dose Packaging Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Single Dose Packaging 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Single Dose Packaging 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Single Dose Packaging Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Single Dose Packaging Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Single Dose Packaging 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Single Dose Packaging 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Single Dose Packaging Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Single Dose Packaging Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Single Dose Packaging 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Single Dose Packaging 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Single Dose Packaging Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Single Dose Packaging Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Single Dose Packaging Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Single Dose Packaging Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Single Dose Packaging Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Single Dose Packaging Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Pharmaceutical Single Dose Packaging Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Single Dose Packaging Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Single Dose Packaging Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Single Dose Packaging Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Pharmaceutical Single Dose Packaging Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Single Dose Packaging Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Single Dose Packaging Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Single Dose Packaging Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Single Dose Packaging Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Pharmaceutical Single Dose Packaging Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Single Dose Packaging Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Single Dose Packaging Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Single Dose Packaging Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Pharmaceutical Single Dose Packaging Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc. Pharmaceutical Single Dose Packaging Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Pharmaceutical Single Dose Packaging Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co. Inc.
6.3.1 Merck & Co. Inc. Corporation Information
6.3.2 Merck & Co. Inc. Description and Business Overview
6.3.3 Merck & Co. Inc. Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co. Inc. Pharmaceutical Single Dose Packaging Product Portfolio
6.3.5 Merck & Co. Inc. Recent Developments/Updates
6.4 Bristol-Myers Squibb Company
6.4.1 Bristol-Myers Squibb Company Corporation Information
6.4.2 Bristol-Myers Squibb Company Description and Business Overview
6.4.3 Bristol-Myers Squibb Company Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Company Pharmaceutical Single Dose Packaging Product Portfolio
6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.5 AbbVie Inc.
6.5.1 AbbVie Inc. Corporation Information
6.5.2 AbbVie Inc. Description and Business Overview
6.5.3 AbbVie Inc. Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Inc. Pharmaceutical Single Dose Packaging Product Portfolio
6.5.5 AbbVie Inc. Recent Developments/Updates
6.6 UDG Healthcare plc
6.6.1 UDG Healthcare plc Corporation Information
6.6.2 UDG Healthcare plc Description and Business Overview
6.6.3 UDG Healthcare plc Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.6.4 UDG Healthcare plc Pharmaceutical Single Dose Packaging Product Portfolio
6.6.5 UDG Healthcare plc Recent Developments/Updates
6.7 Comar LLC
6.6.1 Comar LLC Corporation Information
6.6.2 Comar LLC Description and Business Overview
6.6.3 Comar LLC Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Comar LLC Pharmaceutical Single Dose Packaging Product Portfolio
6.7.5 Comar LLC Recent Developments/Updates
6.8 Berry Global
6.8.1 Berry Global Corporation Information
6.8.2 Berry Global Description and Business Overview
6.8.3 Berry Global Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Berry Global Pharmaceutical Single Dose Packaging Product Portfolio
6.8.5 Berry Global Recent Developments/Updates
6.9 Gerresheimer AG
6.9.1 Gerresheimer AG Corporation Information
6.9.2 Gerresheimer AG Description and Business Overview
6.9.3 Gerresheimer AG Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Gerresheimer AG Pharmaceutical Single Dose Packaging Product Portfolio
6.9.5 Gerresheimer AG Recent Developments/Updates
6.10 Amcor plc
6.10.1 Amcor plc Corporation Information
6.10.2 Amcor plc Description and Business Overview
6.10.3 Amcor plc Pharmaceutical Single Dose Packaging Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Amcor plc Pharmaceutical Single Dose Packaging Product Portfolio
6.10.5 Amcor plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Single Dose Packaging Industry Chain Analysis
7.2 Pharmaceutical Single Dose Packaging Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Single Dose Packaging Production Mode & Process
7.4 Pharmaceutical Single Dose Packaging Sales and 麻豆原创ing
7.4.1 Pharmaceutical Single Dose Packaging Sales Channels
7.4.2 Pharmaceutical Single Dose Packaging Distributors
7.5 Pharmaceutical Single Dose Packaging Customers
8 Pharmaceutical Single Dose Packaging 麻豆原创 Dynamics
8.1 Pharmaceutical Single Dose Packaging Industry Trends
8.2 Pharmaceutical Single Dose Packaging 麻豆原创 Drivers
8.3 Pharmaceutical Single Dose Packaging 麻豆原创 Challenges
8.4 Pharmaceutical Single Dose Packaging 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer Inc.
Johnson & Johnson
Merck & Co. Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UDG Healthcare plc
Comar LLC
Berry Global
Gerresheimer AG
Amcor plc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.